This brand name is authorized in Austria, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Poland, Romania, United Kingdom
The drug RYEQO contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Relugolix
UNII P76B05O5V6 - RELUGOLIX
|
|
Relugolix is a nonpeptide GnRH receptor antagonist that competitively binds to GnRH receptors in the anterior pituitary gland preventing native GnRH from binding and signalling the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Consequently, the production of testosterone from the testes is reduced. |
|
2
Estradiol
UNII CXY7B3Q98Z - ESTRADIOL HEMIHYDRATE
|
|
Estradiol, is chemically and biologically identical to endogenous human estradiol. It substitutes for the loss of oestrogen production in menopausal women, and alleviates menopausal symptoms. Oestrogens prevent bone loss following menopause or ovariectomy. |
|
3
Norethisterone acetate
UNII 9S44LIC7OJ - NORETHINDRONE ACETATE
|
|
Norethisterone has progestational actions similar to those of progesterone, but is a more potent inhibitor of ovulation and has weak oestrogenic and androgenic properties. It is used to treat a number of disorders of the menstrual cycle. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| RYEQO Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| H01CC54 | H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01C Hypothalamic hormones → H01CC Anti-gonadotropin-releasing hormones | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1858103 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 1211565001 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 456735, 565815 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 64049405 |
| Country: IT | Agenzia del Farmaco | Identifier(s): 049616016, 049616028 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1093042 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100455915 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W67879001 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
